to her legions of fans, Lynn Gunn Gunnulfsen made the jump from star to icon years ago.
As the vocalist of dark pop-rock purveyors PVRIS, she spent the bands first two albums, 2014s White Noise and 2017s All We Know of Heaven, All We Need Of Hell, speaking frankly about her own battles with depression, turning reflections of self-doubt and the complexities of relationships into arena-sized slices of electronic fizz. Shes campaigned for LGBTQ+ rights and become a figurehead for countless devotees who have adopted her songs as anthems of bravery and resilience.
The only person who doesnt seem to have grasped the pull of her star power is Gunn herself although thats changing with the release of PVRIS fearless new record, Use Me.
When she announced the album back in March, Gunn revealed that, from day one, shes consistently downplayed her true role as PVRIS sole creative force. Shes been responsible for everything from the bands sound to songwriting, visuals and driving production, but has preferred to share the spotlight with her bandmates, bassist Brian Macdonald and lead guitarist and keyboardist Alex Babinski. With Use Me, though, she says shes finally allowing herself to take credit for PVRIS ever-growing list of achievements.
It feels so good, she says on the phone line from her home in LA, referring to her unmasking as a lifting of the veil. She adds: This had to happen for me to continue wanting to do this. With all the work I was putting into this next record, it felt really weird and uncomfortable to be giving equal credit to everyone. Brian and Alex have always been incredibly supportive of my vision over the years, but I never felt comfortable opening up and owning that role. It made me feel apathetic towards the project.
You need only look at the promotional photos for Use Me, in which Gunn stands defiantly alone, without her bandmates, to see that newfound confidence in action, but she baulks at the suggestion that this is her going solo. Its quite similar to Tame impala and Florence + The Machine; were still very much a band, she says. Everythings operating the same as it always has, its just being presented differently. Her sense of empowerment is plastered all over Use Me.
Wide awake. Just cut the head off of a snake, she sings on the opening line of euphoric, disco-influenced first track, Gimme a Minute, a lyric that finds her looking forward to the future, having let go of the anxieties that plagued her career until now. The new music is also a break with the past, leaning more heavily on the PVRIS lustrous pop inclinations than its predecessors. The bands trademark brooding darkness still bubbles underfoot, but this time its buried beneath slick, vivid production and playful, clubby electronica.
Use Me was originally slated to arrive back in May, but as Covid-19 tightened its grip across the world, the bands label, Reprise/Warner Records, pushed the release to July. After the death of George Floyd in police custody in May, and the subsequent outpouring of shock and revolt and global renewal of the Black Lives Matter movement, Gunn decided that releasing new music would be a distraction from the bigger issues at hand.
In a statement posted to the bands Twitter account in July, she announced that the album would be further delayed: Self-promotion can wait for now and I want to make room and hold space for the conversation and message of the Black Lives Matter movement to continue.
She tells NME today: This moment in time is a paradigm shift and awakening for a lot of people. But theres so much work to do. It has to be lifelong commitment in order to see change.
Gunn recognises that healing the divisions of a splintered America will be a mountainous challenge, but shes inspired by the passion shes seen fighting for change online and out on the streets. In this, shes inspired by the tireless efforts of Gen-Z. We want a better future and are down and willing to be part of that shift, she says. Its so palpable and intense and real. I think the best thing you can do right now, instead of being apathetic and pretending that you dont care, is do care. Youve got to give a shit, you know?
Gunn is now 26, and was only 19 when she wrote the bands debut.When that album was released in 2014, the impact was instant, racking up millions of streams on Spotify and YouTube thanks to gloomy, yet jubilant synth-pop bangers such as St. Patrick and You And I. The record catapulted the band across the globe on a punishing tour schedule, which included high-profile US arena dates with Fall Out Boy, Bring Me The Horizon and Muse. Within three years, they had been booted from clubs onto festival main stages.
The full band, comprise of Gunn, bassist Brian Macdonald and lead guitarist and keyboardist Alex Babinski. Credit: Lindsey Byrnes
Yet success took its toll. By the time Gunn finally sat down to write 2017s All We Know of Heaven, All We Need of Hell, she was knackered and in a dark place, suffering with depression, which shes described as a downward spiral.
Years of constant gigging had damaged her voice, almost leading the band to cancel the tour of their second album while she worked with a vocal coach to retrain herself to sing. In the end, the band ploughed on with the promotion, but Gunns confidence had nosedived and onstage she seemed a reluctant frontwoman, hiding behind a guitar. In later interviews she admitted that she felt exposed and vulnerable.
Around the same time, she was diagnosed with Crohns disease, while in November 2019 it was confirmed that she was also battling an autoimmune disease, ankylosing spondylitis. The diagnoses, she says, came as a strange kind of relief after four years of pain and discomfort.
It has to be lifelong commitment in order to see [social] change
I didnt know what was wrong, she says. I was having a really difficult time getting out and into my bunk every morning and night and waking up with stomach pains. With autoimmune disease, theres a general fatigue and brain fog that comes with chronic inflammation, so a lot of the time Id be really unfocused or really tired. I was hard on myself about it.
Over time, Gunn has found her confidence again. Ive been really on top of my mental and physical health for the last few years, she says. I feel like Ive been in a really good head space for quite a while, which Im really grateful for.
Working with a small team of medical practitioners, including a herbalist, an acupuncture doctor and a womans specialist, who together have slowly but surely helped her to heal and rebalance, she now follows a what she dubs a crazy protocol.
I have up to 20 supplements I need to take, and different droplets, flower essences and plant stem cells, she says. I think theres 16 and you have to take all of them at different points throughout the day. The result has been transformative: Im determined to experience no symptoms in the next five years. Im ready to whoop its ass.
After a few turbulent personal years, Use Me represents a fresh start in many ways. While writing the album she upped sticks to Los Angeles, a move initially borne out of necessity. With an increased focus on protecting her physical and mental health following her Crohns diagnosis, it was clear that her usual approach shuttling back and forth between her home in New York and LA studio sessions had become unworkable. But no-one was more surprised than Gunn to find that her new home city was a genuine source of solace.
Ive always had a love-hate [relationship] with LA, she reveals. Ive had really good things happen here and difficult emotional situations happen here, so for a long time [the city] felt really dark. When I moved here, I was going through a pretty rough time, but I instantly loved it. All my best friends are out here, and I guess it feels like home.
By the time she made the move, she had already written three songs for the album the anthemic Death Of Me, the glossy Old Wounds and the vibrant Hallucinations, which were all released as part of the Hallucinations EP released in October 2019. The latter was penned during writing sessions with hotshot songwriter Amy Allen (whos worked with the likes of Halsey and Harry Styles) and Nashville-based Use Me producer, JT Daly. The remaining songs were finished in Dalys Nashville studio.
If 2017s All We Know of Heaven, All We Need of Hell was a cleansing experience that found Gunn crawling towards the end of the tunnel, its successor captures the moment that she finally emerged from the other end and into the light.
Inner peace is hard to find she sings on the opening line of euphoric, disco-influenced first track, Gimme a Minute, which refers to her overcoming recent emotional and physical upheaval. Over the glassy synths of Deadweight, she discusses walking away from negative mindsets and toxic relationships, sighing, I cant take it over and over / Deadweight hanging off of my shoulders.
[Those songs] capture the chaos of the last two years, she says. Theres so much that Ill never be probably able to share. Youve got to keep changing and growing. If someone or something is attacking you negatively, sometimes youve just got to have the power and the courage to walk away from it.
Is this a reference to long-time drummer Justin Nace, who left the band back in January? At the time the split seemed amicable, but was the shift a result of PVRIS new way of working, with Gunn stepping into the spotlight as band linchpin?
[Our new songs] capture the chaos of the last two years
Sort of, but it was a natural thing that needed to happen, says Gunn hesitantly, seeming reluctant to be drawn on the details. A lot of personal stuff [happened] that Im not going to mention here. Hes never been an official member [of PVRIS] so I dont think its that big a thing to touch on. We love him very much and wish him the best, but now is the time for change and growth for both parties.
The album closes with a reworked version of its titular track, which was put together during lockdown, featuring rising rapper and Kanye West protge 070 Shake. It was such a last-minute blessing from the heavens. I swear, says Gunn. Weve never had a featured artist on an album [before]. Theres never been anyone I was particularly excited about or felt compelled to collab with. I think shes real deal and a really special artist. Her album [070s excellent 2020 record Modus Vivendi] is very experimental, abstract, cool and weird and it takes risks.
Thats something I always want to do with PVRIS so its very aligned creatively. I think shes out in Colorado and as soon as she confirmed it was happening, she ended up having to drive an hour to a studio to track it, sent it over and it was perfect right away. Its a collaboration our fans didnt know they wanted, but hopefully they do now.
PVRIS live in London in February, Credit: India Fleming
Back in February, NME watched the band celebrate their live return to the UK, after two years away, at an intimate London show. As Gunn perched behind a keyboard during Heaven and danced across the stage watched by thousands of adoring eyes, there was no sign of the vocal issues and subsequent nerves that had plagued her in the past. Covid might have stolen that momentum, but Gunn is no longer content to remain trapped inside her inside her chrysalis.
I just want to be real and transparent, she insists. Growing up, I never really had a good example of the artist I am, and the role I take in the band. I just want to show this is an option for anyone who might be a similar position and inspire other people to do the same.
View post:
PVRIS: Sometimes youve got to have the power and the courage to walk away - NME
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021